首页 | 本学科首页   官方微博 | 高级检索  
检索        

低分子肝素钙联合舒利迭吸入治疗急性加重期COPD的疗效观察
引用本文:谢伟国,江莲,侯昕珩.低分子肝素钙联合舒利迭吸入治疗急性加重期COPD的疗效观察[J].职业与健康,2010,26(10):1195-1196.
作者姓名:谢伟国  江莲  侯昕珩
作者单位:东南大学附属江阴市人民医院,江苏省,214400
摘    要:目的探讨低分子肝素钙与舒利迭联合吸入治疗慢性阻塞性肺疾病急性加重期(AECOPD)的治疗价值。方法75例AECOPD病人随机分为低分子肝素钙加舒利迭(A)组和单用舒利迭(B)组,其余治疗相同。结果A组较B组在最大呼气流量(PEF)、症状计分、PaO2、PaCO2等方面差异有统计学意义(P0.05);同组病人治疗前后差异有统计学意义(P0.01);A组凝血酶原时间延长小于1倍,无出血现象。结论低分子肝素钙联合舒利迭吸入治疗AECOPD,安全、有效,具有推广价值。

关 键 词:低分子肝素钙  舒利迭  慢性阻塞性肺疾病  急性加重期

Clinical Observation on Inhalation of Low Molecular Weight Heparin Calcium Combined with Seretide in Treatment of Acute Exacerbation of COPD
XIE Wei-guo,JIANG Lian,HOU Xin-heng.Clinical Observation on Inhalation of Low Molecular Weight Heparin Calcium Combined with Seretide in Treatment of Acute Exacerbation of COPD[J].Occupation and Health,2010,26(10):1195-1196.
Authors:XIE Wei-guo  JIANG Lian  HOU Xin-heng
Institution:XIE Wei-guo,JIANG Lian,HOU Xin-heng (Department of Respiration,Affiliated Jiangyin Hospital of Southeast University,Jiangsu,214400,China)
Abstract:Objective]To study the therapeutic value of inhalation of low molecular weight heparin calcium combined with seretide in treatment of acute exacerbation of COPD (AECOPD).Methods]75 patients with AECOPD were divided into group A (low molecular weight heparin calcium combined with seretide) and group B (single seretide),and other treatments were same in two groups.Results]There were significant differences in peak expiratory flow (PEF),symptom scores,PaO2 and PaCO2 between group A and B (P<0.05).The differ...
Keywords:Low molecular weight heparin calcium  Seretide  Chronic obstructive pulmonary diseases  Acute exacerbation  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号